HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Hakkari or alpha 2 beta 2 31(B13)Leu-->Arg, a severely unstable hemoglobin variant associated with numerous intra-erythroblastic inclusions and erythroid hyperplasia of the bone marrow.

Abstract
A severely unstable hemoglobin variant, Hb Hakkari or alpha 2 beta 2 31 (B13)Leu-->Arg, has been observed in a 5-year-old Turkish girl with a severe hemolytic anemia without Heinz body formation. A modest increase in liver and spleen size was present and the level of Hb F was a high 33%. The variant could not be observed in red cells and was only detected through sequencing of the amplified beta-globin gene and also by hybridization with specific oligonucleotide probes. The parents were normal, and it is assumed that the variant occurred as a de novo mutation. Smears from bone marrow aspirates showed numerous inclusion bodies in the erythroblast and, as a result, a erythroid hyperplasia. It is suggested that the hemoglobin variant which is unstable and is readily losing its heme group because one of the heme binding sites has been lost, precipitates in the erythroblasts, thus interfering with the maturation process and causing the severe anemia.
AuthorsA Gürgey, C Altay, L H Gu, J Y Leonova, A Delibalta, C Oner, T H Huisman
JournalHemoglobin (Hemoglobin) 1995 May-Jul Vol. 19 Issue 3-4 Pg. 165-72 ISSN: 0363-0269 [Print] England
PMID7558872 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin Hakkari
  • Globins
Topics
  • Anemia, Hemolytic, Congenital (genetics, pathology)
  • Base Sequence
  • Bone Marrow (pathology)
  • Child, Preschool
  • DNA Mutational Analysis
  • Erythroblasts (pathology)
  • Female
  • Globins (genetics)
  • Hemoglobins, Abnormal (genetics)
  • Humans
  • Hyperplasia (genetics)
  • Inclusion Bodies (pathology)
  • Molecular Sequence Data
  • Point Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: